BPC-157 Dosage Calculator: Your Complete Guide to Tissue Healing
Calculate your ideal BPC-157 dose with our dosing charts, reconstitution guide, and administration protocols for injury recovery and tissue repair.
- BPC-157 is a synthetic peptide of 15 amino acids, derived from a protein found in human gastric juice, studied mainly in preclinical models for tissue healing and inflammation.
- Most of the evidence is from animal studies. Human evidence is limited to a few small, uncontrolled pilot studies, with no randomized controlled trials.
- There is no FDA approved or clinically validated human dose. Ranges discussed in clinical practice commonly fall in the low hundreds of micrograms daily, but your provider sets your specific dose.
- Accurate dosing depends on your vial concentration after reconstitution and the units you draw on an insulin syringe. This guide shows how to measure correctly.
- BPC-157 requires a prescription and provider supervision, and it is prohibited in tested sport.
Important: BPC-157 is classified by the FDA as a Category 2 bulk drug substance and is not approved for human use. It remains an investigational compound. Compounded versions are not FDA-reviewed for safety, quality, or efficacy.
In this article
This guide explains how BPC-157 dosing works, how to reconstitute and administer it accurately, and what to expect, in a format built for physician prescribed therapy. It has two jobs. First, it helps you understand BPC-157 before a consultation, so you can have a more informed conversation with a provider. Second, once you have a prescription, it shows you how to prepare and measure the exact dose your provider sets, accurately and safely. It is preparation and execution support, not a substitute for a prescription. This page does not set your dose. Your provider does.
Important safety and regulatory status. BPC-157 is not approved by the FDA for human use. It is an investigational compound, and compounded versions are not FDA reviewed for safety, quality, or efficacy. Its status is also actively changing: in April 2026 the FDA removed BPC-157 from Category 2 of the 503A bulk substances list, where it had been placed in 2023 over insufficient safety data, and referred it to the Pharmacy Compounding Advisory Committee for a meeting on July 23 to 24, 2026. Removal from Category 2 is not approval. Confirm current status with your provider, and use BPC-157 only under licensed supervision.
What is BPC-157, and how is it thought to work?
BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide, meaning it is made of 15 amino acids. It is based on a protective protein found in human gastric juice. It has drawn interest for its potential to support healing across tendons, ligaments, muscles, and the gut lining. These mechanisms are characterized mainly in laboratory and animal research, which gives BPC-157 a plausible rationale but is not the same as proven results in people. Proposed actions include supporting angiogenesis, the formation of new blood vessels, influencing growth factor pathways such as VEGF and EGR-1, supporting collagen production, helping normalize nitric oxide signaling, and modulating inflammation.
What determines your dose?
Because BPC-157 is not an approved medication, there is no official dosing chart and no validated human dose. What follows are the factors your provider weighs and the ranges commonly discussed in clinical practice. These are context, not a prescription.
Factors that influence dosing include the condition being addressed, its severity, body weight and overall health, the administration route, and how you respond over time. Daily amounts discussed in clinical and community settings commonly fall in the low hundreds of micrograms, often split into two administrations to keep levels steadier, though once daily is also used. The table of ranges below is illustrative only, and none of these figures are established guidelines, which is exactly why a prescriber individualizes them.
Ranges often discussed in practice, not FDA validated:
Understanding the dose math
Here is the part of a dosage calculator that genuinely protects you. Once your provider prescribes a dose in micrograms, you need to draw the correct number of units on your syringe, and getting that wrong is one of the few real, avoidable risks in self administration. The first step is knowing your concentration after reconstitution, which depends on how much bacteriostatic water you add to the powder.
Independent reviews note there is no standardized or FDA validated human dose for BPC-157, and that figures circulating online derive from clinic and community practice rather than controlled trials.
Frequently Asked Questions
What is the correct dose of BPC-157?
There is no FDA approved or clinically validated human dose. The numbers and weight based formulas circulating online come from clinic practice and forums, not controlled trials, so they are not official guidelines. Your prescribing provider determines whether BPC-157 is appropriate and sets your specific dose. This guide helps you measure that prescribed dose accurately, not choose it yourself.
How do I convert my prescribed dose into syringe units?
Use this formula with a U-100 insulin syringe: units to draw equals the prescribed dose in micrograms divided by your concentration in micrograms per milliliter, multiplied by 100. Your concentration depends on how much bacteriostatic water you added during reconstitution, so always recalculate if your vial size or water amount changes. If your pharmacy provides a units figure, use theirs and treat this math as a check.
How much bacteriostatic water should I add?
That depends on the vial size and the concentration your provider or pharmacy specifies. Adding more water lowers the concentration, which means more units for the same dose, and adding less raises it. Follow the amount your provider or pharmacy directs rather than choosing arbitrarily, since the amount of water determines your unit math.
Can I adjust my dose if it does not seem to be working?
No, not on your own. If you see little change after about two weeks, or you notice anything unexpected, tell your provider, who can reassess and adjust the protocol safely. Changing the dose of an investigational compound yourself is not advisable. Dose decisions belong with your prescriber.
Oral or injectable, which should I use?
It depends on the goal and should be decided with your provider. Injection delivers more to the bloodstream and is usually chosen for systemic and musculoskeletal goals, while oral forms are used mainly for gut focused goals, where the peptide can act locally. Oral systemic absorption is lower and not well characterized in humans.
Is BPC-157 approved and allowed in sport?
BPC-157 is not FDA approved, and its compounding status is under review in 2026. It should be treated as prohibited in tested sport, so any athlete subject to testing should confirm current rules with their governing body. Because compounded products are not held to the quality standards of approved drugs, sourcing and pharmacy quality also matter.
Converting a prescribed dose into units
With your concentration known, converting a prescribed dose into syringe units is straightforward. The worked example below uses a 5 mg vial reconstituted with 1 ml, giving 5,000 micrograms per milliliter. If your concentration differs, the same dose draws a different number of units, so always recalculate.
The second example shows the same doses at a lower concentration, a 5 mg vial reconstituted with 2 ml, giving 2,500 micrograms per milliliter. Notice that each dose now requires twice as many units.
If your provider or pharmacy gives you a units figure, use theirs, and use this math only to confirm it makes sense.
Reconstitution: mixing your BPC-157 correctly
Proper reconstitution keeps the peptide intact and your doses accurate. You will need the lyophilized powder vial, bacteriostatic water, sterile syringes, alcohol swabs, and a clean surface. Clean your hands and the surface, then wipe the rubber stoppers of both vials with alcohol swabs and let them air dry. Draw the amount of bacteriostatic water your provider or pharmacy specified, insert the needle at an angle, and aim the stream at the glass wall rather than directly onto the powder, adding it slowly to avoid foaming. Let the vial rest for 10 to 20 minutes, rolling it gently between your palms if needed, and never shake it, since that can damage the peptide. The solution should be clear and colorless. Do not use it if it is cloudy, discolored, or has visible particles.
For storage, refrigerate at 36 to 46 F, which is 2 to 8 C, immediately after mixing, keep it away from light, and use it within 4 weeks. Unreconstituted powder can be stored frozen at minus 4 F, which is minus 20 C, for longer shelf life. Avoid repeated freeze and thaw cycles.
Administration
Choose the route with your provider. Subcutaneous injection into the fatty layer under the skin is the most common route for general tissue repair. Intramuscular injection is sometimes used for localized muscle issues and needs professional guidance. Oral or sublingual forms are used mainly for gut focused goals. For subcutaneous injection, common sites are the abdomen about two inches from the navel, the front or outer thigh, and the back of the upper arm, and sites should be rotated with each dose to reduce irritation. Follow the sterile technique your provider or pharmacy teaches. There is no proven best time of day, so follow the schedule your provider sets, whether that is morning, bedtime, post workout, or split dosing.
What to expect
Responses vary by person and injury, and benefit is not guaranteed. People often describe a gradual pattern: subtle changes at most in the first week, sometimes with mild and temporary injection site reactions, more noticeable changes between weeks two and four if it is going to help, and fuller effects, if any, settling in by weeks four to eight depending on severity. Cycles commonly run 2 to 8 weeks, sometimes longer for severe cases, with a break before any repeat. Your provider will guide cycle length and repeats.
When to contact your provider
Rather than adjusting your own dose, share what you notice with your provider. Tell them if you see little or no change after about two weeks, since they may reassess the plan, and tell them promptly about anything unexpected, such as unusual fatigue, persistent injection site reactions, or new symptoms. Do not increase, decrease, or combine doses on your own.
Side effects and combination protocols
Based on the limited available research, BPC-157 is generally described as well tolerated, with reported effects usually mild, such as injection site reactions, occasional nausea more associated with oral use, and rare dizziness or headache. Because human safety data are limited and long term effects are unknown, several cautions matter: BPC-157 promotes angiogenesis, which in theory could affect tumor growth, so anyone with a history of cancer should discuss it carefully, and it should not be used during pregnancy or breastfeeding.
Some providers and users discuss combining BPC-157 with other peptides, such as TB-500 or GHK-Cu. These combinations are not supported by controlled human trials and compound the unknowns of using more than one unapproved compound at once. If a combination is ever appropriate, it should be decided and directed by your provider, including how products are prepared, rather than assembled from online protocols.
Conclusion
A useful BPC-157 dosage calculator does two honest things: it explains what influences a dose, and it helps you measure a prescribed dose accurately. It does not hand a layperson a self selected dose of an unapproved compound. There is no FDA validated human dose, the meaningful ranges come from clinical practice rather than trials, and the most protective skill is converting a prescribed dose into the right syringe units given your concentration. Pair that with careful reconstitution, sterile administration, correct storage, and open communication with your provider, and you have the practical foundation for using prescribed BPC-157 safely, with realistic expectations.
Disclaimer
This information is for educational purposes only and is not medical advice. It does not set or recommend a dose, and it does not establish a provider patient relationship. BPC-157 is not FDA approved, is not an established treatment, and its regulatory status can change. Do not start, stop, or change any therapy based on this content. Always consult a licensed healthcare provider before starting any peptide therapy, and follow the dose and protocol they prescribe. Individual results vary.
In this article
